Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 21,118 shares at $81.20 ($1.7M) on 2017-03-09, disclosed to the SEC on 2017-03-10.
Open-market sale of $1.7M KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.47 | 12,127 | $976K | 57.2% |
| 2 | $81.20 | 8,991 | $730K | 42.8% |
| Total | $80.78 avg | 21,118 | $1.7M | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-07-11 | $906K | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |